Evidence map›Paper›PMID 27489033›Full record

SynthesisScientific reports2016

The association of three promoter polymorphisms in interleukin-10 gene with the risk for colorectal cancer and hepatocellular carcinoma: A meta-analysis.

Yan-Hui Shi, Dong-Mei Zhao, Yue-Fei Wang, Xue Li, Man-Ru Ji, Dan-Na Jiang, Bai-Ping Xu, Li Zhou, Chang-Zhu Lu, Bin Wang

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yan-Hui ShiDepartment of Gastroenterology, The First Hospital of Qiqihar City, Qiqihar, Heilongjiang, China.
Dong-Mei ZhaoDepartment of Gastroenterology, The First Hospital of Qiqihar City, Qiqihar, Heilongjiang, China.
Yue-Fei WangDepartment of Physiology, Qiqihar Medical University, Qiqihar, Heilongjiang, China.
Xue LiDepartment of Physiology, Qiqihar Medical University, Qiqihar, Heilongjiang, China.
Man-Ru JiDepartment of Gastroenterology, The First Hospital of Qiqihar City, Qiqihar, Heilongjiang, China.
Dan-Na JiangDepartment of Gastroenterology, The First Hospital of Qiqihar City, Qiqihar, Heilongjiang, China.
Bai-Ping XuIntervention Therapy Department, The First Hospital of Qiqihar City, Qiqihar, Heilongjiang, China.
Li ZhouCentral Laboratory, Qiqihar Medical University, Qiqihar, Heilongjiang, China.
Chang-Zhu LuDepartment of Physiology, Qiqihar Medical University, Qiqihar, Heilongjiang, China.
Bin WangDepartment of Physiology, Qiqihar Medical University, Qiqihar, Heilongjiang, China.
Qiqihar Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mounting evidence supports a potent inhibitory role of interleukin-10 (IL-10) in tumor carcinogenesis, angiogenesis and metastasis. This meta-analysis was designed to examine the association of three promoter polymorphisms (-592C > A, -819C > T and -1082G > A) in IL-10 gene with the risk for colorectal cancer and hepatocellular carcinoma. Qualification assessment and data collection were completed by two authors independently. The random-effects model using the DerSimonian and Laird method was fitted by the STATA software. Twenty-five articles involving 5933 cases and 9724 controls were meta-analyzed. Overall comparisons of the mutant alleles (-592A, -819T and -1082A) of three promoter polymorphisms with alternative wild alleles failed to reveal any statistical significance for both colorectal cancer and hepatocellular carcinoma (P > 0.05), and the likelihood of heterogeneity was low (I(2) < 50%). For -592C > A polymorphism, a significant risk for colorectal cancer was identified when analysis was restricted to East Asians (odds ratio or OR = 1.41, 95% confidence interval or CI: 1.18-1.68, P < 0.001) and retrospective studies (OR = 1.23, 95% CI: 1.09-1.39, P = 0.001). As weighed by the Egger's test and the fill-and-trim method, there was a low probability of publication bias for all studied polymorphisms. Our findings collectively suggest that the -592C > A polymorphism in IL-10 gene might be a susceptibility locus for colorectal cancer in East Asians.

Indexed as

Genetic Predisposition to DiseaseAsian PeopleCarcinoma, HepatocellularColorectal NeoplasmsHumansInterleukin-10Liver NeoplasmsPolymorphism, Single NucleotidePromoter Regions, GeneticIL10 protein, humanInterleukin-10

Identifiers

PMID27489033
PMCPMC4973248
OpenAlexW2501001740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.